Evaluation Of Peripheral Neuropathy Research Articles

Evaluation of Peripheral Neuropathy in Rat Models of Metabolic Syndrome and Diabetes Mellitus.

The dynamics of nephropathy development in rats with type 2 diabetes mellitus, caused by a high-fat diet and the streptozotocin administration (25 mg/kg), and metabolic syndrome, caused by addition of 20% fructose solution to the diet, was evaluated during the experiment. Models with moderate severity of metabolic changes without significant changes in body weight were obtained after 24 weeks. To study neuropathy severity, the method of electroneuromyography was used; the velocities of motor and sensory excitation propagation along the caudal nerve fibers were measured. In modeled diabetes mellitus against the background of hyperglycemia, a marked decrease in motor and sensory propagation rates was observed, and an increase in the response durations was noted from week 12 to week 24, indicating pronounced neuropathy. In the fructose model, the motor response duration increased from week 12, which possibly indicates the development of peripheral neuropathy.

High-Resolution Ultrasound in Evaluation of Peripheral Neuropathy in Patients of Hansen's Disease.

Hansen's disease (HD) is a major public health problem in developing countries. It causes peripheral neuropathy, and if left untreated, it leads to deformities. It is important to diagnose such cases early, and prompt treatment should be given to patients to preserve nerve function. A total of 40 patients with HD who were already on multi-drug therapy (MDT) or treatment-naive were included in this study. These were clinically diagnosed cases of HD as per the Ridley-Jopling classification, and these patients were subjected to high-resolution ultrasonography (HRUS). A total of 19 controls were also included. The patients were clinically evaluated, and HRUS of bilateral ulnar nerves (UNs) was performed in all cases and controls. The other peripheral nerves, if clinically thickened, were evaluated using HRUS. The cross-sectional area (CSA) of the UN in cases was significantly thickened as compared to controls. There was no difference in the CSA of patients on MDT as compared to treatment naïve patients. In two patients with pure neuritic HD, the clinical examination missed the bilateral nerve enlargement, and only unilateral nerve thickening was clinically appreciated. However, bilateral thickening was detected on HRUS. HRUS is a non-invasive and sensitive diagnostic tool that gives significant information on nerve structure and morphology. HRUS adds a new dimension to diagnosing HD, particularly the pure neuritic type, with the assessment of early nerve damage, which can prevent disabilities. HRUS is an objective diagnostic tool that can complement the clinical examination.

Quantitative sensory testing in a large cohort of neuropathy patients

Background:
 Quantitative sensory testing (QST) is a subjective but reliable and quantifiable method to detect patient thresholds to different sensory stimuli. QST is used to measure small- and large-fiber nerve function and can be used in conjunction with other diagnostic modalities in the evaluation of peripheral neuropathy (PN). The utility of QST to distinguish among different types of PN, however, has not been explored. The objective of the study was to evaluate if different patterns of QST abnormalities could distinguish between PN types.
 Methods:
 This single-center retrospective cohort study evaluated the frequency of QST abnormalities to vibratory, cold and heat detection thresholds in a large population of PN cases evaluated at the University of Texas Southwestern Medical Center peripheral neuropathy clinic between 1995-2000. PN was categorized by etiology.
 Results:
 A total of 559 QST studies were performed in this study. The average age of patients (n=557) was 60 years with a male-to-female ratio of 1:1. The most common diagnosis was cryptogenic sensory polyneuropathy (CSPN, n=294), followed by Charcot–Marie–Tooth disease (n=84)). Meta-regression of vibration and cold indicate that the expected proportion of abnormal responses is less for the vibration test (p = 0.0002), relative to the cold test. However, no differences were observed between diagnoses.
 Conclusions:
 Though abnormal QST thresholds were seen in most patients with PN, patterns of QST abnormalities do not distinguish between different types of PN. The routine clinical utility of QST is likely limited.

TU-238. The role of electromyography and ultrasonography in the evaluation of peripheral neuropathy in systemic vasculitis

TU-238. The role of electromyography and ultrasonography in the evaluation of peripheral neuropathy in systemic vasculitis

Spatial variation in mechanical properties along the sciatic and tibial nerves: An ultrasound shear wave elastography study

Ultrasound shear wave elastography has become a promising method in peripheral neuropathy evaluation. Shear wave velocity, a surrogate measure of stiffness, tends to increase in peripheral neuropathies regardless of etiology. However, little is known about the spatial variation in shear wave velocity of healthy peripheral nerves and how tensile loading is distributed along their course. Sixty healthy young adults were scanned using ultrasound shear wave elastography. Five regions of the sciatic (SciaticPROXIMAL, SciaticDISTAL) and tibial nerve (TibialPROXIMAL, TibialINTERMEDIATE, and TibialDISTAL) were assessed in two hip positions that alter nerve tension: 1) neutral in supine position; and 2) flexed at 90°. Knee and ankle remained in full-extension and neutral position. We observed spatial variations in shear wave velocity along the sciatic and tibial nerve (P < 0.0001). Shear wave velocities were significantly different between all nerve locations with the exception of SciaticDISTAL vs. TibialINTERMEDIATE (P = 0.999) and TibialPROXIMAL vs. TibialINTERMEDIATE (P = 0.708), and tended to increase in the proximal-distal direction at both upper and lower leg segments. Shear wave velocity increased with hip flexion (+54.3%; P < 0.0001), but the increase was not different among nerve locations (P = 0.233). This suggests that the increase in tensile loading with hip flexion is uniformally distributed along the nerve tract. These results highlight the importance of considering both limb position and transducer location for biomechanical and clinical assessments of peripheral nerve stiffness. These findings provide evidence about how tension is distributed along the course of sciatic and tibial nerves.

Evaluation of peripheral neuropathy in lower limbs of patients with rheumatoid arthritis and its relation to fall risk

BackgroundRheumatoid Arthritis (RA) is a chronic disabling systemic disease characterized by joint inflammation, and extra-articular manifestations, including peripheral neuropathy, a condition that can be associated with changes in muscle strength, proprioception and postural balance contributing for the risk of falls. The objective of this study is to analyze the incidence of peripheral neuropathy in patients with RA and its association with the occurrence of falls.MethodsPatients were assessed by an electroneuromyography (ENMG) exam and by a questionnaire on accidental falls occurrence in the previous 12 months. They were also assessed on balance by the Short Physical Performance Battery (SPPB), functionality by the Health Assessment Questionnaire (HAQ), disease activity by the Disease Activity Score (DAS-28), neuropathic pain by the Questionnaire for the Diagnosis of Neuropathic Pain (DN4), and cutaneous sensitivity of the feet by the monofilament testing of Semmes–Weinstein. Monthly calls on falls were made in the subsequent six months. Data analysis was performed using the Shapiro–Wilk test for normality and Spearman, Chi-square, and T-student correlation tests, with a significant P level ≤ 0.05.ResultsA sample of 33 patients were evaluated. The incidence of peripheral neuropathy was 48.5%, of which 68.7% were axonal and 31.3% myelinic. The sensorimotor type was present in 64.7%, motor in 17.6%, and sensorial in 11.7% of the cases. Neuropathy was associated to balance (P = 0.026), neuropathic pain (P = 0.016), deep tendon reflexes absence (P = 0,049), altered skin sensitivity of the feet (P = 0.029) and fear of falling (P = 0.001). No association was found between peripheral neuropathy and age, gender, disease activity, or functionality. No significant association was found between peripheral neuropathy and occurrence of falls, in a 12-month retrospective and 6-month prospective evaluation.ConclusionPeripheral neuropathy has a high incidence in patients with RA, and is related to neuropathic pain, altered postural balance, but not to the occurrence of falls.

PROSPECTIVE STUDY OF BEDSIDE ASSESSMENT OF DIABETIC PERIPHERAL NEUROPATHY

Background: Diabetic peripheral sensorimotor neuropathy is one of the most prevalent neuropathic syndromes affecting around 50 % people with diabetes. Its development is gradual with subtle changes hence ignored. Early diagnosis using simple bedside tools is essential. Methods: The prospective study of evaluation of peripheral neuropathy in diabetes involved examination of 500 diabetic patients for neuropathy. Pinprick, vibration sensation, perception of 5.07 Semmes Weinstein monofilament and Achilles tendon reflex were examined and impairment noted. Results: 39 % patients had impairment of perception of Semmes Weinstein monofilament. Loss of pinprick sensation was found in 65.6 % in patients with diabetes for 5-10 years duration. Abnormal tendon reflex was seen in 64.2 % in patients with diabetes move than 10 years. Loss of Vibration (40.2 %), Wasting (16.6 %), loss of pinprick sensation (44.5%) and loss of abnormal tendon reflex (32.1 %) was found to be more common in type II diabetes. Conclusion: Sensorimotor peripheral neuropathy was more common in long standing diabetes mellitus especially with impaired glycaemic control and type II diabetes mellitus.

WS7.5. Neuromuscular ultrasound of the lower extremities

Neuromuscular ultrasound is rapidly evolving as an excellent diagnostic tool in the evaluation of peripheral neuropathies, especially so in focal neuropathies. It can be of use in understanding the underlying pathological mechanism of neuropathies. Focal neuropathies are more likely to be associated with structural abnormalities that can be easily recognized by imaging modalities. Certain subtypes of polyneuropathies are also associated with morphological changes. Point of care ultrasound helps with rapid examination of long segments of multiple nerves in the out-patient setting. This can result in early triaging of patients and rapid management decisions. Other advantages include easy patient tolerability when compared to nerve conduction studies and lower cost. The sonographic abnormalities that are commonly associated with neuropathies include focal or diffuse enlargement, hour-glass constriction, change in neural architecture, decreased mobility of the nerve and increased vascularity of the nerves. It can also be of use in detecting extra-neural abnormalities like tenosynovitis, soft tissue tumors, entrapment or compression from metallic implants. Peripheral nerves of the lower extremities that can be commonly assessed by sonographic studies include the sciatic, peroneal and tibial nerve. Other less common nerves that are assessed include the lateral femoral cutaneous nerve, the superficial and deep peroneal nerves and the sural nerves. It can also be of value in the evaluation of the digital nerves in the feet. Clinical conditions where sonographic studies can be of paramount importance include evaluation of the peroneal nerve at the fibular head in patients presenting with foot drop and assessment of the tibial nerve in the tarsal tunnel in those presenting with unilateral foot numbness. Its use as a diagnostic tool has extended beyond focal neuropathies to include polyneuropathies secondary to metabolic, inherited and inflammatory causes. Other uses of lower extremity ultrasound include its role as a tool in guiding with therapeutic interventions like steroid injections and detection of morphological changes within cutaneous nerves prior to consideration of nerve biopsy.

Role of shear wave elastography in treatment follow-up of leprosy neuropathy.

Grayscale ultrasonography when complemented with shear wave elastography helps in better evaluation of treatment response of leprosy neuropathy and in guiding appropriate management of the patient. There is limited literature regarding the use of shear wave elastography in ulnar nerve neuropathy. Our purpose was to evaluate the role of shear wave elastography in assessing stiffness changes within the ulnar nerve during treatment of leprosy. This was a prospective study which included 30 patients diagnosed with leprosy neuropathy. Recruited patients were followed up, during the course of treatment, i.e. for 1year. Serial ultrasonography of these patients was done at 0, 3, 6 and 12months interval. Significant (P < 0.05) decrease in elastography parameters was seen in transverse imaging plane between first and third, as well as first and fourth visits (mean stiffness and velocity pretreatment ~ 25.78 ± 18kPa and 2.74 ± 0.98m/s, mean stiffness and velocity post-treatment 15.67 ± 5.89kPa and 2.24 ± 0.428m/s). Although elastography parameters decreased during these visits in the long-axis imaging plane, they were not found to be statistically significant. However, gross morphology and cross-sectional area of the nerve did not change significantly across visits. Interestingly, elastography values were higher in patients with neuritis, though not statistically significant. Shear wave elastography is a novel, upcoming modality in musculoskeletal imaging especially in the evaluation of peripheral neuropathy. It can act as an adjunct to grey-scale imaging, which can help in early diagnosis and in guiding treatment of leprosy neuropathy.

Shear wave elastography of the median nerve: A mechanical study.

Shear wave elastography (SWE) shows promise in peripheral neuropathy evaluation but has potential limitations due to tissue size and heterogeneity. We tested SWE sensitivity to elasticity change and the effect of probe position in a median nerve cadaver model. Ten specimens were used to measure median nerve elasticity under increasing loads using SWE and indentation. Measurements were compared using repeated-measures analysis of variance. Indentation and SWE-based longitudinal nerve elasticity increased with tensile loading (P < .01), showing a similar relationship. Acquisition in a transverse plane showed lower values compared with longitudinal measurements, mostly under higher loads (P = .03), as did postdissection elasticity (P = .02). Elasticity did not change when measured proximal to the carpal tunnel. Longitudinal SWE is sensitive to changes in median nerve elasticity. Measuring elasticity of peripheral nerves noninvasively could elucidate intra-neural pathology related to compression neuropathies, and proof to be of added value as a diagnostic or prognostic tool.

The Evaluation of Peripheral Neuropathy, Daily Life Activities and Quality of Life in Cancer Patients

The Evaluation of Peripheral Neuropathy, Daily Life Activities and Quality of Life in Cancer Patients

Peripheral nerve magnetic resonance imaging.

Magnetic resonance imaging (MRI) has been used extensively in revealing pathological changes in the central nervous system. However, to date, MRI is very much underutilized in evaluating the peripheral nervous system (PNS). This underutilization is generally due to two perceived weaknesses in MRI: first, the need for very high resolution to image the small structures within the peripheral nerves to visualize morphological changes; second, the lack of normative data in MRI of the PNS and this makes reliable interpretation of the data difficult. This article reviews current state-of-the-art capabilities in in vivo MRI of human peripheral nerves. It aims to identify areas where progress has been made and those that still require further improvement. In particular, with many new therapies on the horizon, this review addresses how MRI can be used to provide non-invasive and objective biomarkers in the evaluation of peripheral neuropathies. Although a number of techniques are available in diagnosing and tracking pathologies in the PNS, those techniques typically target the distal peripheral nerves, and distal nerves may be completely degenerated during the patient’s first clinic visit. These techniques may also not be able to access the proximal nerves deeply embedded in the tissue. Peripheral nerve MRI would be an alternative to circumvent these problems. In order to address the pressing clinical needs, this review closes with a clinical protocol at 3T that will allow high-resolution, high-contrast, quantitative MRI of the proximal peripheral nerves.

A Clinician's Approach to Peripheral Neuropathy.

Peripheral neuropathies are a group of disorders that affect the peripheral nervous system, for which hundreds of etiologies have been identified. This article presents a stepwise approach to the evaluation and workup of peripheral neuropathy, which starts with a detailed history of symptoms, family and occupational history, and a neurological as well as general physical exam. Pattern recognition of various neuropathies can help to build a differential diagnosis based on the presentation. Such patterns include acute versus chronic, primary demyelinating versus axonal, hereditary versus acquired, asymmetric versus symmetric, presence of facial palsies, sensory or motor predominant, and presence of prominent autonomic symptoms. Early categorization of the type of neuropathy can help focus the workup for peripheral neuropathy. Nerve conduction studies and electromyography (NCS/EMG) is the primary diagnostic tool in the evaluation of patients with large-fiber polyneuropathy. One of the most important roles of NCS/EMG is to help categorize polyneuropathy as primary axonal versus primary demyelinating. The finding of a primary demyelinating polyneuropathy narrows the differential diagnosis of polyneuropathy dramatically and increases the chances of finding a treatable etiology. Laboratory workup includes serum studies and potentially cerebrospinal fluid, genetic studies, immunological markers, and fat pad biopsy for select patients. Skin biopsy may be used to assess intraepidermal nerve fiber density if small-fiber neuropathy is suspected, and nerve biopsy may be useful in select cases. In recent years, magnetic resonance imaging and neuromuscular ultrasound have also shown promise in the evaluation of peripheral neuropathy. Identification of the etiology of neuropathy is crucial and often time-sensitive, as an increasing number of causes are now reversible or treatable.

S14-4. Evaluation of peripheral neuropathy with electrical threshold measurement

S14-4. Evaluation of peripheral neuropathy with electrical threshold measurement

Ultrasound elastography for the evaluation of peripheral nerves: A systematic review.

Peripheral nerve disorders are commonly encountered in clinical practice. Electrodiagnostic studies remain the cornerstone of the evaluation of nerve disorders. More recently, ultrasound has played an increasing complementary role in the neuromuscular clinic. Ultrasound elastography is a technique that measures the elastic properties of tissues. Given the histological changes that occur in diseased peripheral nerves, nerve ultrasound elastography has been explored as a noninvasive way to evaluate changes in nerve tissue composition. Studies to date suggest that nerve stiffness tends to increase in the setting of peripheral neuropathy, regardless of etiology, consistent with loss of more compliant myelin, and replacement with connective tissue. The aim of this systematic review is to summarize the current literature on the use of ultrasound elastography in the evaluation of peripheral neuropathy. Limitations of ultrasound elastography and gaps in current literature are discussed, and prospects for future clinical and research applications are raised.

Ultrasound elastography in the evaluation of peripheral neuropathies: a systematic review of the literature.

Peripheral neuropathy is associated with an increase in intraneural pressure, and hence ultrasound elastography seems to be an ideal method to detect early stages of this condition based on changes in the affected nerve stiffness. The aim of this systematic review was to analyse the applicability of strain elastography (SE) and shear wave elastography (SWE) in the evaluation of peripheral nerves in patients with neuropathy of various aetiologies. Published evidence shows clearly that ultrasound elastography can accurately diagnose many types of peripheral neuropathies (carpal tunnel syndrome and other entrapment neuropathies, diabetic peripheral neuropathy and peripheral neuropathy associated with other systemic diseases), sometimes at the stages at which the condition is still asymptomatic. However, it is still unclear whether elastographic changes within the nerves precede functional anomalies detectable on nerve conduction studies. Also, relatively little is known about the relationship between the stiffness of peripheral nerves and the severity of peripheral neuropathy and its underlying condition. Based on the reproducibility data, SWE seems to be superior to SE. Nevertheless, the sources of heterogeneity in the peripheral nerve stiffness in healthy persons need to be identified, and the sets of reference values for specific peripheral nerves need to be determined. Finally, the potential confounding effect of hardening artefacts, such as bones, on the stiffness of peripheral nerves needs to be verified. After addressing all these issues, elastographic evaluation of peripheral nerve stiffness might become a reliable, easily accessible, and convenient diagnostic test performed routinely in patients with various peripheral neuropathies.

The first Japanese case of biopsy‐confirmed small‐fiber neuropathy related to celiac disease

AbstractA 26‐year‐old lady presented with a rapidly progressive burning pain in both feet. She had been bothered by bloating after wheat‐containing foods since the age of 21. Her gastrointestinal symptoms alleviated after introducing gluten‐free diet. On admission, neurological examination was unremarkable without dysesthesia with normal nerve conduction studies. Skin biopsy specimen showed decreased intraepidermal nerve fiber density, indicating small‐fiber neuropathy. Besides, clinical symptoms, duodenal biopsy, and positive HLA‐DQ2 and ‐DQ8 suggested celiac disease, which might be associated with small‐fiber neuropathy. Intravenous immunoglobulin was not efficacious. Celiac disease should be considered in the evaluation of peripheral neuropathy.

Evaluation of Peripheral Neuropathy in Diabetic Adults with and without Foot Ulcers in an African Population

Background: Foot ulcers frequently precede lower extremity amputations (LEA) in diabetic subjects. Peripheral neuropathy (PN) is a strong risk factor for diabetic foot ulceration. Majority of diabetic patients with PN are asymptomatic; hence foot ulceration may be the first clinical presentation. Early detection of PN can forestall the development of foot ulcers through active preventive strategies. Few studies have been done to assess PN in diabetic individuals in Africa. The study aims to evaluate the incidence and risk factors for PN in diabetic adults with and without foot ulcers in an indigenous African population. Method: This cross-sectional study involved 90 diabetic adults, 45 with foot ulcers and 45 without foot ulcers. Assessment of PN was done with the Michigan Neuropathy Screening Instrument (MNSI), the 10 g Semmes-Weinstein monofilament (SWM) and the 128-Hz vibrating tuning fork (VTF). Demographic data were collected by questionnaire. Associations between PN and risk factors such as age, alcohol consumption, duration of diabetes, cigarette smoking, BMI, height and sex were also investigated. Results: There were 59 males (65.6%) and 31 females (34.4%) in the study. The mean age of the subjects with foot ulcers was 59.62 years (SD = 6.47), while those without ulcers was 57.47 years (SD = 6.94). Forty-two subjects (93.33%) with foot ulcers have PN using the MNSI, while 33 subjects without foot ulcers (73.33%) have PN. Both the SWM and the VTF showed a high positive correlation with themselves and with the MNSI. Advancing age, duration of diabetes, alcohol intake, hyperglycaemia and cigarette smoking showed a significant association with peripheral neuropathy, while BMI, height and sex did not. Conclusion: The incidence of PN is quite high in diabetic adults in Africa. This calls for early screening and aggressive control of risk factors to prevent the development of diabetic foot ulceration.

Evaluation of peripheral neuropathy and associated risk factors in patients with beta-thalasemia major

Background: β–thalassemia major is a lifelong transfusion dependent disease. Thalassemia patients suffer from skeletal changes, hepatosplenomegaly, and neuropathy resulted from anemia, iron overload or chelating therapy. The aim of this study was to determined prevalence of peripheral neuropathy in patients with β–thalassemia major, and to evaluate the effect of other factors, such as ferritin level, DFO (Desferrioxamine) dose, gender, splenectomy and age on the incidence of this disorder.

Imaging Nerve Pathology of the Knee: Magnetic Resonance Imaging and Ultrasound.

Peripheral neuropathies are not uncommon, and the diagnostic evaluation includes a clinical assessment and electrophysiologic studies as well as diagnostic imaging. Magnetic resonance imaging (MRI) and high-resolution ultrasound (HRUS) are of special importance in providing the surgeon with information in the context of nerve trauma, entrapment, and nerve involvement by tumors. Peripheral neuropathy about the knee can occur in the context of associated knee pathology such as trauma, as part of a systemic disease, or as an isolated finding. In this review, we discuss the role of MRI and HRUS in the evaluation of peripheral neuropathy and present imaging examples of peripheral neuropathy involving the knee.